🇺🇸 FDA
Pipeline program

TACE and HAIC Combined With Regorafenib

2022519

Phase 2 other completed

Quick answer

TACE and HAIC Combined With Regorafenib for Liver Metastasis Colon Cancer is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Liver Metastasis Colon Cancer
Phase
Phase 2
Modality
other
Status
completed

Clinical trials